Negative Symptoms and Cognitive Deficits Predict Different Elements of Everyday Functioning in People with Schizophrenia

被引：0
作者：
Harvey, Philip [1 ]
机构：
[1] Univ Miami, Coral Gables, FL 33124 USA
来源：
BIOLOGICAL PSYCHIATRY | 2017年 / 81卷 / 10期
关键词：
Negative Symptoms; Neurocognition; functional capacity; Everyday functioning;
D O I：
10.1016/j.biopsych.2017.02.371
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
354
引用
收藏
页码：S145 / S145
页数：1
相关论文
共 50 条
  • [31] The Relationship of Social Cognition, to Neurocognition, Negative Symptoms and Social Functioning in Patients with Schizophrenia
    Khan, Anzalee
    Opler, Mark
    Lindenmayer, Jean-Pierre
    Rothman, Brian
    Lucic, Luka
    BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 266S - 267S
  • [32] Neural Activity During Cognitive Empathy is Associated With Social Functioning and Negative Symptoms in Schizophrenia: Preliminary Analyses
    Jimenez, Amy
    Hasratian, Arpi S.
    Myers, Ana Ceci
    Reavis, Eric A.
    Wynn, Jonathan K.
    Yen, Melodie
    Green, Michael
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 359 - 360
  • [33] Metacognitive deficits predict future levels of negative symptoms in schizophrenia controlling for neurocognition, affect recognition, and self-expectation of goal attainment
    Lysaker, Paul H.
    Kukla, Marina
    Dubreucq, Julien
    Gumley, Andrew
    McLeod, Hamish
    Vohs, Jenifer L.
    Buck, Kelly D.
    Minor, Kyle S.
    Luther, Lauren
    Leonhardt, Bethany L.
    Belanger, Elizabeth A.
    Popolo, Raffaele
    Dimaggio, Giancarlo
    SCHIZOPHRENIA RESEARCH, 2015, 168 (1-2) : 267 - 272
  • [34] Relationships between cognitive deficits, symptoms and quality of life in schizophrenia
    Savilla, Kara
    Kettler, Lisa
    Galletly, Cherrie
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2008, 42 (06) : 496 - 504
  • [35] Differential Cognitive Deficits of Two Negative Symptom Domains in Schizophrenia
    Sevy, Serge
    Lindenmayer, Jean-Pierre
    Khan, Anzalee
    McGurk, Susan R.
    Ljuri, Isidora
    Thanju, Amod
    Goldring, Abraham
    Parak, Mohan
    Parker, Benedicto
    BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S318 - S318
  • [36] A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia
    Buchanan, Robert W.
    Kelly, Deanna L.
    Weiner, Elaine
    Gold, James M.
    Strauss, Gregory P.
    Koola, Maju M.
    McMahon, Robert P.
    Carpenter, William T.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (04) : 394 - 400
  • [37] Nicotine Fails to Attenuate Ketamine-Induced Cognitive Deficits and Negative and Positive Symptoms in Humans: Implications for Schizophrenia
    D'Souza, Deepak Cyril
    Ahn, Kyungheup
    Bhakta, Savita
    Elander, Jacqueline
    Singh, Nagendra
    Nadim, Haleh
    Jatlow, Peter
    Suckow, Raymond F.
    Pittman, Brian
    Ranganathan, Mohini
    BIOLOGICAL PSYCHIATRY, 2012, 72 (09) : 785 - 794
  • [38] Deep transcranial magnetic stimulation add-on for treatment of negative symptoms and cognitive deficits of schizophrenia: a feasibility study
    Levkovitz, Yechiel
    Rabany, Liron
    Harel, Eiran Vadim
    Zangen, Abraham
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2011, 14 (07) : 991 - 996
  • [39] Negative and Cognitive Symptoms of Schizophrenia: Are there Adequate Pharmacological Treatments?
    Vasiliu, O.
    EUROPEAN PSYCHIATRY, 2022, 65 : S776 - S776
  • [40] The role of negative symptoms and cognitive dysfunction in schizophrenia outcome
    Tamminga, CA
    Buchanan, RW
    Gold, JM
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1998, 13 : S21 - S26
12345